Asuncion, Paraguay. 8th Dec, 2021. Illustration: In-camera multiple exposure image shows logos of Pfizer and BioNTech on smartphone in front of the designation ''Omicron (B.1.1.529)'' and visual representation of virus, medical syringe and ampoules labeled COVID-19. Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. (Credit Image: © Andre M. Chang/ZUMA Press Wire)
Contributor:ZUMA Press, Inc. / Alamy Stock Photo
File size:63.3 MB (1.9 MB Compressed download)
Releases:Model - no | Property - noDo I need a release?
Dimensions:5760 x 3840 px | 48.8 x 32.5 cm | 19.2 x 12.8 inches | 300dpi
Date taken:8 December 2021
This image could have imperfections as it’s either historical or reportage.